-       Report 
- October 2025
-  192 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  196 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  189 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Clinical Trials 
- April 2025
-  50 Pages 
- Global 
   From       €1073EUR$1,200USD£944GBP 
      €1342EUR$1,500USD£1,180GBP 
             -       Report 
- October 2025
-  148 Pages 
- Global 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
            -       Report 
- August 2025
-  150 Pages 
- Global 
   From       €3003EUR$3,358USD£2,642GBP 
      €3533EUR$3,950USD£3,108GBP 
          -       Report 
- March 2025
-  210 Pages 
- Global 
   From       €4468EUR$4,995USD£3,930GBP 
          -       Report 
- November 2024
-  90 Pages 
- North America 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Report 
- November 2024
-  90 Pages 
- Europe 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Report 
- November 2024
-  93 Pages 
- Asia Pacific 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Report 
- November 2024
-  84 Pages 
- Africa, Middle East 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Report 
- November 2024
-  100 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
            -       Report 
- October 2025
-  180 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  199 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  184 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  177 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Drug Pipelines 
- April 2025
-  60 Pages 
- Global 
   From       €1073EUR$1,200USD£944GBP 
      €1342EUR$1,500USD£1,180GBP 
            -       Clinical Trials 
- April 2025
-  60 Pages 
- Global 
   From       €1073EUR$1,200USD£944GBP 
      €1342EUR$1,500USD£1,180GBP 
       
      Analgesics are a class of drugs used to relieve pain. Opioids are a type of analgesic that act on the nervous system to reduce the intensity of pain signals sent to the brain. Opioids are typically prescribed for moderate to severe pain, and are often used to treat chronic pain. They can be taken orally, injected, or applied topically. Opioids can be highly addictive and have a high potential for abuse, so they are typically prescribed with caution.
Opioids are a major component of the analgesic    market, and are used to treat a variety of conditions. Commonly prescribed opioids include oxycodone, hydrocodone, morphine, and codeine. Other analgesics, such as non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen, are also used to treat pain.
Companies in the opioids market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Johnson & Johnson. Show Less   Read more